Artificial Intelligence (AI) Powered Remote Electrocardiogram (ECG) Monitoring Market Report 2025

The artificial intelligence (AI)-powered remote electrocardiogram (ECG) monitoring market size has grown exponentially in recent years. It will grow from $1.34 billion in 2024 to $1.61 billion in 2025 at a compound annual growth rate (CAGR) of 20.4%. The growth during the historic period is driven by rising incidence of arrhythmias and heart failure, increasing awareness of cardiac health, development of cloud-based healthcare platforms, expansion of hospital-led remote monitoring programs, and growing demand for continuous real-time cardiac monitoring.

The artificial intelligence (AI)-powered remote electrocardiogram (ECG) monitoring market size is expected to see exponential growth in the next few years. It will grow to $3.34 billion in 2029 at a compound annual growth rate (CAGR) of 20%. The projected growth in the forecast period is supported by rising prevalence of cardiovascular diseases, greater adoption of telemedicine, increasing demand for remote patient monitoring, an aging global population, and higher healthcare costs driving home-based care. Key trends in this period include advancements in AI algorithms for arrhythmia detection, innovations in wearable ECG devices, integration of cloud-based analytics with ECG monitoring, progress in real-time remote patient monitoring, and developments in predictive cardiac health management.

The increasing adoption of telemedicine is expected to drive the growth of the artificial intelligence (AI)-powered remote electrocardiogram (ECG) monitoring market. Telemedicine uses digital communication technologies to deliver healthcare services remotely, allowing patients to consult doctors, receive diagnoses, and manage treatments without needing to visit healthcare facilities. This method is gaining popularity due to its convenience, offering patients the ability to access healthcare services remotely, saving time, and eliminating the need for travel, thus improving overall accessibility and efficiency. AI-powered remote ECG monitoring enhances telemedicine by enabling continuous heart monitoring, which is crucial for remote patient care. It improves diagnostic accuracy by automatically detecting irregular heart rhythms, supporting timely clinical interventions and increasing patient convenience. For instance, a survey conducted in February 2023 by Rock Health, a U.S.-based nonprofit, found that 80% of respondents had used telemedicine at least once, an 8% increase from 2021. As telemedicine adoption grows, it fuels the expansion of AI-powered remote ECG monitoring.

Leading companies in the AI-powered remote ECG monitoring market are focusing on developing advanced solutions, such as AI-driven arrhythmia detection tools, to improve diagnostic accuracy, enhance patient outcomes, and reduce healthcare costs. These tools use artificial intelligence to automatically analyze ECG data and identify irregular heart rhythms, enabling early detection, real-time alerts, and better cardiac care. For example, in April 2024, BIOTRONIK, a Germany-based medical technology company, launched the BIOMONITOR IV insertable cardiac monitor with AI capabilities. This device is designed to improve arrhythmia detection and patient management. Equipped with advanced AI algorithms, it analyzes cardiac signals in real-time, accurately identifying clinically significant arrhythmias while minimizing false positives. The BioMonitor IV ICM includes automated rhythm classification and adaptive monitoring, allowing for proactive intervention and personalized treatment plans without requiring manual data review by clinicians.

In May 2024, WearLinq Inc., a US-based remote cardiac monitoring company, acquired AMI Cardiac Monitoring LLC, a provider of AI-powered remote ECG monitoring solutions, for an undisclosed sum. This acquisition allows WearLinq to expand its clinical services across the country, gain access to AMI's established patient base, and enhance its ability to offer FDA-cleared 6-lead wearable ECG monitoring solutions for arrhythmia detection and patient management.

Major players in the artificial intelligence (AI) powered remote electrocardiogram (ECG) monitoring market are Koninklijke Philips N.V., GE Healthcare, Masimo Corporation, Biotronik SE & Co. KG, Nihon Kohden Corporation, iRhythm Technologies Inc., Biofourmis Pte. Ltd., BioSerenity Inc., Withings SA, Eko Devices Inc., AliveCor Inc., Compumedics Limited, Anumana Inc., Electrical Geodesics Inc. (EGI), InfoBionic Inc., Neurable Inc., Cardiomatics Sp. z o.o., IDOVEN S.L., Zeto Inc., and NextGen Neuro Inc.

North America was the largest region in the artificial intelligence (AI) powered remote electrocardiogram (ECG) monitoring market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI) powered remote electrocardiogram (ECG) monitoring report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the artificial intelligence (AI) powered remote electrocardiogram (ECG) monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

Artificial intelligence (AI)-powered remote electrocardiogram (ECG) monitoring is a technology-driven system that enables continuous or on-demand monitoring of a patient’s heart activity from a remote location. It uses AI algorithms to analyze ECG data in real time, detect abnormalities, and provide actionable insights to healthcare providers. This technology supports early diagnosis, reduces clinical workload, and promotes proactive cardiac care.

The primary components of AI-powered remote ECG monitoring include hardware, software, and services. Hardware consists of physical devices such as wearable monitors, ECG machines, sensors, electrodes, and mobile devices. These systems can be deployed on-premises or via cloud-based platforms. Applications include epilepsy monitoring, sleep disorder tracking, brain-computer interface studies, neurodevelopmental disorder assessment, and other areas. Key end users include hospitals and clinics, ambulatory surgical centers, home care providers, research institutes, and similar organizations.

The artificial intelligence (AI)-powered remote electrocardiogram (ECG) monitoring market research report is one of a series of new reports that provides artificial intelligence (AI)-powered remote electrocardiogram (ECG) monitoring market statistics, including the artificial intelligence (AI)-powered remote electrocardiogram (ECG) monitoring industry global market size, regional shares, competitors with the artificial intelligence (AI)-powered remote electrocardiogram (ECG) monitoring market share, detailed artificial intelligence (AI)-powered remote electrocardiogram (ECG) monitoring market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-powered remote electrocardiogram (ECG) monitoring industry. This artificial intelligence (AI)-powered remote electrocardiogram (ECG) monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial intelligence (AI) powered remote electrocardiogram (ECG) monitoring market consists of revenues earned by entities by providing services such as continuous remote heart rhythm tracking, AI-driven arrhythmia and cardiac anomaly detection, real-time data transmission and analysis, patient risk stratification, and predictive alerts for adverse cardiac events. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) powered remote electrocardiogram (ECG) monitoring market also includes sales of AI-enabled wearable ECG devices, portable ECG monitors, wireless ECG sensors, cloud-connected diagnostic platforms, mobile health applications, and integrated software solutions. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.